Clinical Trials Browser

Metastatic gpNMB Expressing Triple Negative Breast Cancer × glembatumumab vedotin × Breast × Clear all

NCT03067935 2018-05-21

Individual Patient Expanded Access-Glembatumumab Vedotin

No longer available

Metastatic gpNMB Expressing Triple Negative Breast Cancer